MEFLOQUINE PHARMACOKINETICS AND RESISTANCE IN CHILDREN WITH ACUTE FALCIPARUM-MALARIA

被引:29
作者
NOSTEN, E
TERKUILE, F
CHONGSUPHAJAISIDDHI, T
BANGCHANG, KN
KARBWANG, J
WHITE, NJ
机构
[1] MAHIDOL UNIV, FAC TROP MED, 420-6 RAJVITHI RD, BANGKOK 10400, THAILAND
[2] UNIV AMSTERDAM, DIV MED, SUB DIV TROP MED, AMSTERDAM, NETHERLANDS
[3] UNIV OXFORD, NUFFIELD DEPT CLIN MED, OXFORD, ENGLAND
基金
英国惠康基金;
关键词
MEFLOQUINE; MALARIA; DRUG RESISTANCE;
D O I
10.1111/j.1365-2125.1991.tb05581.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetic properties of mefloquine hydrochloride (15 mg base kg-1) were studied in 12 Karen children (five girls, seven boys) aged between 5 and 10 years presenting with uncomplicated falciparum malaria. The drug was well tolerated. Mean (s.d.) peak blood drug concentrations of 2031 (831) ng ml-1 were reached in a median of 8 (range 6-24) h. Mean (s.d.) estimates for oral clearance and mean residence time were 0.52 (0.27) ml min-1 kg-1 and 15.3 (4.7) days, respectively. These values are similar to those reported previously in adults. In one child parasitaemia failed to clear despite whole blood mefloquine concentrations which peaked at 1744 ng ml-1; parasitaemia rose and fever recurred when blood drug concentrations had fallen to 442 ng ml-1. The prevalence of highly mefloquine resistant parasites such as this can be expected to increase under drug pressure in this area.
引用
收藏
页码:556 / 559
页数:4
相关论文
共 15 条
  • [1] INTRAGASTRIC MEFLOQUINE IS ABSORBED RAPIDLY IN PATIENTS WITH CEREBRAL MALARIA
    CHANTHAVANICH, P
    LOOAREESUWAN, S
    WHITE, NJ
    WARRELL, DA
    WARRELL, MJ
    DIGIOVANNI, JH
    VONBREDOW, J
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1985, 34 (06) : 1028 - 1036
  • [2] HELLGREN U, 1989, B WORLD HEALTH ORGAN, V67, P197
  • [3] MEFLOQUINE DISPOSITION IN NORMALS AND IN PATIENTS WITH SEVERE PLASMODIUM-FALCIPARUM MALARIA
    JUMA, FD
    OGETO, JO
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1989, 14 (01) : 15 - 17
  • [4] PLASMA AND WHOLE-BLOOD MEFLOQUINE CONCENTRATIONS DURING TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM-MALARIA WITH THE COMBINATION MEFLOQUINE-SULFADOXINE-PYRIMETHAMINE
    KARBWANG, J
    LOOAREESUWAN, S
    PHILLIPS, RE
    WATTANAGOON, Y
    MOLYNEUX, ME
    NAGACHINTA, B
    BACK, DJ
    WARRELL, DA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) : 477 - 481
  • [5] KARBWANG J, 1988, B WORLD HEALTH ORGAN, V66, P763
  • [6] CLINICAL PHARMACOKINETICS OF MEFLOQUINE
    KARBWANG, J
    WHITE, NJ
    [J]. CLINICAL PHARMACOKINETICS, 1990, 19 (04) : 264 - 279
  • [7] A COMPARISON OF THE PHARMACOKINETICS OF MEFLOQUINE IN HEALTHY THAI VOLUNTEERS AND IN THAI PATIENTS WITH FALCIPARUM-MALARIA
    KARBWANG, J
    BACK, DJ
    BUNNAG, D
    BRECKENRIDGE, AM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (06) : 677 - 680
  • [8] STUDIES OF MEFLOQUINE BIOAVAILABILITY AND KINETICS USING A STABLE ISOTOPE TECHNIQUE - A COMPARISON OF THAI PATIENTS WITH FALCIPARUM-MALARIA AND HEALTHY CAUCASIAN VOLUNTEERS
    LOOAREESUWAN, S
    WHITE, NJ
    WARRELL, DA
    FORGO, I
    DUBACH, UG
    RANALDER, UB
    SCHWARTZ, DE
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (01) : 37 - 42
  • [9] MEFLOQUINE ANTIMALARIAL PROPHYLAXIS IN PREGNANCY - DOSE FINDING AND PHARMACOKINETIC STUDY
    NOSTEN, F
    KARBWANG, J
    WHITE, NJ
    BANGCHANG, KN
    BUNNAG, D
    HARINASUTA, T
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) : 79 - 85
  • [10] NOSTEN F, 1987, B WORLD HEALTH ORGAN, V65, P891